Innovation Pharmaceuticals Inc (IPIX)

[frenchbroad]

If you want to attack a small biotech company like Ipix you must start with one question. Is the company science good or not good?

If the science is not good the job is easy. Learn everything possible and demonstrate the science is not good. Tell everyone the bad evidence. It should be finished quickly if the science is not good.

If the science is good it is more work. Creativity is maybe necessary in the attack. Here are some options.
> The science is maybe not safe. This can be effective if the drug has not advance more than a Phase 2.clinical test.
> The company management is stupid or criminal or both. All small companies make mistakes. Find the mistakes and build a story in corruption and foolishness.
> The company will run out of money and fail. Every small biotech like Ipix needs a partner to go forward. If there is no partner and little money it is possible to build disappointment and despair for a good story.
> The market for the science is too small. Not enough people need the drug and no one will make any money. This one will not work well for Ipix and Brilacidin. But it is worth to try.

A European pharmaceutical company will discuss Brilacidin in their internal licensing meeting in 3 weeks. I know this direct from the company and not from Ipix. We will see how the Ipix stories change into the future.